FOXO1 and colorectal carcinoma: Additionally, melatonin reduces endothelin-1, which acts as a survival factor in CRC, expression and secretion in CRC cells through the inactivation of FoxO-1 and NF-κβ, leading to angiogenesis inhibition, thereby limiting development and progression of CRC [36,37].